Suvretta Capital Management
Latest statistics and disclosures from Suvretta Capital Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are BHVN, SPY, ARQT, ITCI, LEGN, and represent 27.53% of Suvretta Capital Management's stock portfolio.
- Added to shares of these 10 stocks: LEGN (+$114M), IMTX (+$36M), KO (+$34M), RCKT (+$32M), TGTX (+$30M), BA (+$28M), CZR (+$26M), APLS (+$25M), DDOG (+$25M), NVDA (+$24M).
- Started 18 new stock positions in UAL, IMTX, BMY, BA, DDOG, MRK, SRPT, RCKT, ELV, NVDA. LEGN, CZR, PVLA, DIS, APLS, KZR, DPZ, TGTX.
- Reduced shares in these 10 stocks: SPY (-$117M), AAPL (-$78M), ACLX (-$58M), RPRX (-$53M), , UNH (-$36M), CRWD (-$29M), KDP (-$26M), LVS (-$24M), INTC (-$24M).
- Sold out of its positions in T, ALNY, AAPL, ACLX, TECH, CVS, CNTA, ILMN, INTC, FXI. KVUE, KDP, Kezar Life Sciences, KWEB, LVS, Marinus Pharmaceuticals, PINS, TEVA, WYNN, RPRX.
- Suvretta Capital Management was a net seller of stock by $-87M.
- Suvretta Capital Management has $2.9B in assets under management (AUM), dropping by -6.12%.
- Central Index Key (CIK): 0001569064
Tip: Access up to 7 years of quarterly data
Positions held by Suvretta Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Suvretta Capital Management
Suvretta Capital Management holds 96 positions in its portfolio as reported in the December 2024 quarterly 13F filing
Company (Ticker) |
Portfolio Weight |
Valued At |
Change in Shares |
Share Count |
Share Price |
|
|---|---|---|---|---|---|---|
| Biohaven (BHVN) | 7.2 | $210M | +8% | 5.6M | 37.35 |
|
| Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY) | 7.0 | $205M | -36% | 350k | 586.08 |
|
| Arcutis Biotherapeutics (ARQT) | 5.4 | $159M | +6% | 11M | 13.93 |
|
| Intra Cellular Therapies (ITCI) | 4.1 | $120M | 1.4M | 83.52 |
|
|
| Legend Biotech Corp Sponsored Ads (LEGN) | 3.9 | $114M | NEW | 3.5M | 32.54 |
|
| Benitec Biopharma Com New (BNTC) | 3.9 | $113M | 9.0M | 12.63 |
|
|
| Insmed Com Par $.01 (INSM) | 3.8 | $111M | 1.6M | 69.04 |
|
|
| Meta Platforms Cl A (META) | 3.4 | $100M | 170k | 585.51 |
|
|
| 89bio (ETNB) | 2.7 | $80M | +27% | 10M | 7.82 |
|
| Amazon (AMZN) | 2.6 | $77M | 351k | 219.39 |
|
|
| Apollo Global Mgmt (APO) | 2.6 | $77M | 464k | 165.16 |
|
|
| Coca-Cola Company (KO) | 2.4 | $71M | +93% | 1.1M | 62.26 |
|
| Taiwan Semiconductor Mfg Sponsored Ads (TSM) | 2.3 | $68M | 346k | 197.49 |
|
|
| Tesla Motors (TSLA) | 2.3 | $66M | -15% | 164k | 403.84 |
|
| Arrivent Biopharma (AVBP) | 2.0 | $60M | +21% | 2.2M | 26.64 |
|
| Eyepoint Pharmaceuticals Com New (EYPT) | 1.7 | $51M | +31% | 6.8M | 7.45 |
|
| Microsoft Corporation (MSFT) | 1.7 | $50M | +22% | 118k | 421.50 |
|
| Ultragenyx Pharmaceutical (RARE) | 1.7 | $48M | 1.2M | 42.07 |
|
|
| Starbucks Corporation (SBUX) | 1.6 | $47M | -6% | 515k | 91.25 |
|
| Capital One Financial (COF) | 1.5 | $45M | +6% | 252k | 178.32 |
|
| Kura Oncology (KURA) | 1.5 | $44M | -33% | 5.1M | 8.71 |
|
| Ferguson Enterprises Common Stock New (FERG) | 1.5 | $43M | +9% | 246k | 173.57 |
|
| Goldman Sachs (GS) | 1.4 | $43M | -31% | 74k | 572.62 |
|
| Kalvista Pharmaceuticals (KALV) | 1.4 | $42M | +16% | 4.9M | 8.47 |
|
| Advanced Micro Devices (AMD) | 1.4 | $41M | -2% | 337k | 120.79 |
|
| CRH Ord (CRH) | 1.4 | $40M | -19% | 436k | 92.52 |
|
| UnitedHealth (UNH) | 1.3 | $38M | -48% | 75k | 505.86 |
|
| Oracle Corporation (ORCL) | 1.3 | $38M | -4% | 226k | 166.64 |
|
| Immatics SHS (IMTX) | 1.2 | $36M | NEW | 5.1M | 7.11 |
|
| Boston Scientific Corporation (BSX) | 1.2 | $36M | +58% | 398k | 89.32 |
|
| Ge Aerospace Com New (GE) | 1.1 | $34M | 201k | 166.79 |
|
|
| Rocket Pharmaceuticals (RCKT) | 1.1 | $32M | NEW | 2.6M | 12.57 |
|
| Erasca (ERAS) | 1.1 | $31M | -10% | 12M | 2.51 |
|
| McDonald's Corporation (MCD) | 1.0 | $30M | 104k | 289.89 |
|
|
| Verizon Communications (VZ) | 1.0 | $30M | -2% | 738k | 39.99 |
|
| Tg Therapeutics Call Option (TGTX) | 1.0 | $30M | NEW | 980k | 30.10 |
|
| Boeing Company (BA) | 0.9 | $28M | NEW | 155k | 177.00 |
|
| Caesars Entertainment (CZR) | 0.9 | $26M | NEW | 772k | 33.42 |
|
| Apellis Pharmaceuticals (APLS) | 0.9 | $25M | NEW | 793k | 31.91 |
|
| Datadog Cl A Com (DDOG) | 0.9 | $25M | NEW | 177k | 142.89 |
|
| Contineum Therapeutics Cl A (CTNM) | 0.9 | $25M | 1.7M | 14.65 |
|
|
| NVIDIA Corporation (NVDA) | 0.8 | $24M | NEW | 181k | 134.29 |
|
| Prokidney Corp Class A Ord Shs (PROK) | 0.7 | $21M | 12M | 1.69 |
|
|
| Abeona Therapeutics Com New (ABEO) | 0.7 | $21M | 3.7M | 5.57 |
|
|
| Johnson & Johnson (JNJ) | 0.7 | $20M | 140k | 144.62 |
|
|
| Hldgs (UAL) | 0.7 | $20M | NEW | 201k | 97.10 |
|
| Biogen Idec (BIIB) | 0.6 | $18M | +285% | 115k | 152.92 |
|
| Domino's Pizza (DPZ) | 0.5 | $16M | NEW | 38k | 419.76 |
|
| Fulcrum Therapeutics (FULC) | 0.5 | $16M | +182% | 3.3M | 4.70 |
|
| Inflarx Nv (IFRX) | 0.5 | $14M | 5.7M | 2.47 |
|
|
| Sutro Biopharma (STRO) | 0.5 | $14M | +3% | 7.5M | 1.84 |
|
| Crowdstrike Hldgs Cl A (CRWD) | 0.4 | $12M | -70% | 36k | 342.16 |
|
| Zura Bio Class A Ord Shs (ZURA) | 0.4 | $12M | 4.9M | 2.50 |
|
|
| Monte Rosa Therapeutics (GLUE) | 0.4 | $11M | -41% | 1.6M | 6.94 |
|
| Molecular Partners Ads (MOLN) | 0.4 | $11M | +455% | 2.2M | 4.75 |
|
| Walt Disney Company (DIS) | 0.4 | $11M | NEW | 95k | 111.35 |
|
| Arcus Biosciences Incorporated (RCUS) | 0.3 | $8.6M | -13% | 576k | 14.89 |
|
| Palvella Therapeutics Inc Ne (PVLA) | 0.3 | $8.6M | NEW | 715k | 12.00 |
|
| Bioage Labs (BIOA) | 0.3 | $8.4M | 1.5M | 5.79 |
|
|
| Scpharmaceuticals (SCPH) | 0.2 | $6.5M | -10% | 1.8M | 3.54 |
|
| Sanofi Sponsored Adr (SNY) | 0.2 | $6.3M | -24% | 132k | 48.23 |
|
| Ge Healthcare Technologies I Common Stock (GEHC) | 0.2 | $5.9M | 75k | 78.18 |
|
|
| EXACT Sciences Corporation (EXAS) | 0.2 | $5.3M | 94k | 56.19 |
|
|
| Merck & Co (MRK) | 0.2 | $5.3M | NEW | 53k | 99.48 |
|
| Kezar Life Sciences Com New (KZR) | 0.2 | $4.8M | NEW | 717k | 6.72 |
|
| Pepgen (PEPG) | 0.2 | $4.5M | -29% | 1.2M | 3.79 |
|
| Thermo Fisher Scientific (TMO) | 0.1 | $4.1M | +8% | 7.9k | 520.23 |
|
| Abbott Laboratories (ABT) | 0.1 | $3.8M | 34k | 113.11 |
|
|
| Danaher Corporation (DHR) | 0.1 | $3.1M | -17% | 14k | 229.55 |
|
| Elanco Animal Health (ELAN) | 0.1 | $3.1M | 254k | 12.11 |
|
|
| AmerisourceBergen (COR) | 0.1 | $2.8M | 13k | 224.68 |
|
|
| Intuitive Surgical Com New (ISRG) | 0.1 | $2.7M | 5.2k | 521.96 |
|
|
| Dex (DXCM) | 0.1 | $2.5M | 32k | 77.77 |
|
|
| Mettler-Toledo International (MTD) | 0.1 | $2.4M | 2.0k | 1223.68 |
|
|
| Sarepta Therapeutics (SRPT) | 0.1 | $2.2M | NEW | 18k | 121.59 |
|
| Bristol Myers Squibb (BMY) | 0.1 | $1.9M | NEW | 34k | 56.56 |
|
| Natera (NTRA) | 0.1 | $1.6M | 10k | 158.30 |
|
|
| Stryker Corporation (SYK) | 0.1 | $1.6M | 4.4k | 360.05 |
|
|
| Avantor (AVTR) | 0.1 | $1.5M | 72k | 21.07 |
|
|
| Iqvia Holdings (IQV) | 0.0 | $1.4M | 7.2k | 196.51 |
|
|
| Medtronic SHS (MDT) | 0.0 | $1.4M | 18k | 79.88 |
|
|
| Waters Corporation (WAT) | 0.0 | $1.2M | 3.2k | 370.98 |
|
|
| McKesson Corporation (MCK) | 0.0 | $1.0M | 1.8k | 569.91 |
|
|
| Galapagos Nv Spon Adr (GLPG) | 0.0 | $1.0M | -21% | 37k | 27.50 |
|
| Anthem (ELV) | 0.0 | $1.0M | NEW | 2.7k | 368.90 |
|
| Hca Holdings (HCA) | 0.0 | $958k | 3.2k | 300.15 |
|
|
| Edwards Lifesciences (EW) | 0.0 | $822k | 11k | 74.03 |
|
|
| Agilent Technologies Inc C ommon (A) | 0.0 | $670k | 5.0k | 134.34 |
|
|
| Veralto Corp Com Shs (VLTO) | 0.0 | $558k | 5.5k | 101.85 |
|
|
| ResMed (RMD) | 0.0 | $547k | 2.4k | 228.69 |
|
|
| Ionis Pharmaceuticals (IONS) | 0.0 | $378k | 11k | 34.96 |
|
|
| Zimmer Holdings (ZBH) | 0.0 | $344k | 3.3k | 105.63 |
|
|
| Steris Shs Usd (STE) | 0.0 | $315k | 1.5k | 205.56 |
|
|
| Pacs Group Com Shs (PACS) | 0.0 | $262k | 20k | 13.11 |
|
|
| Baxter International (BAX) | 0.0 | $232k | 8.0k | 29.16 |
|
|
| Align Technology (ALGN) | 0.0 | $229k | 1.1k | 208.51 |
|
Past Filings by Suvretta Capital Management
SEC 13F filings are viewable for Suvretta Capital Management going back to 2013
- Suvretta Capital Management 2024 Q4 filed Feb. 14, 2025
- Suvretta Capital Management 2024 Q3 filed Nov. 14, 2024
- Suvretta Capital Management 2024 Q2 filed Aug. 14, 2024
- Suvretta Capital Management 2024 Q1 filed May 15, 2024
- Suvretta Capital Management 2023 Q3 filed Nov. 14, 2023
- Suvretta Capital Management 2023 Q2 filed Aug. 14, 2023
- Suvretta Capital Management 2023 Q1 filed May 15, 2023
- Suvretta Capital Management 2022 Q4 filed Feb. 14, 2023
- Suvretta Capital Management 2022 Q3 filed Nov. 14, 2022
- Suvretta Capital Management 2022 Q2 filed Aug. 15, 2022
- Suvretta Capital Management 2022 Q1 filed May 16, 2022
- Suvretta Capital Management 2021 Q4 filed Feb. 14, 2022
- Suvretta Capital Management 2021 Q3 restated filed Nov. 16, 2021
- Suvretta Capital Management 2021 Q3 filed Nov. 15, 2021
- Suvretta Capital Management 2021 Q3 amended filed Nov. 15, 2021
- Suvretta Capital Management 2021 Q2 filed Aug. 16, 2021